Search Results
Search for other papers by Charlene Diepenbroek in
Google Scholar
PubMed
Search for other papers by Leslie Eggels in
Google Scholar
PubMed
Search for other papers by Mariëtte T Ackermans in
Google Scholar
PubMed
Search for other papers by Eric Fliers in
Google Scholar
PubMed
Hypothalamic Integration Mechanisms, Netherlands Institute for Neuroscience, Amsterdam, the Netherlands
Search for other papers by Andries Kalsbeek in
Google Scholar
PubMed
Search for other papers by Mireille J Serlie in
Google Scholar
PubMed
Search for other papers by Susanne E la Fleur in
Google Scholar
PubMed
We showed previously that rats on a free-choice high-fat, high-sugar (fcHFHS) diet become rapidly obese and develop glucose intolerance within a week. Interestingly, neither rats on a free-choice high-fat diet (fcHF), although equally obese and hyperphagic, nor rats on a free-choice high-sugar (fcHS) diet consuming more sugar water, develop glucose intolerance. Here, we investigate whether changes in insulin sensitivity contribute to the observed glucose intolerance and whether this is related to consumption of saturated fat and/or sugar water. Rats received either a fcHFHS, fcHF, fcHS or chow diet for one week. We performed a hyperinsulinemic–euglycemic clamp with stable isotope dilution to measure endogenous glucose production (EGP; hepatic insulin sensitivity) and glucose disappearance (Rd; peripheral insulin sensitivity). Rats on all free-choice diets were hyperphagic, but only fcHFHS-fed rats showed significantly increased adiposity. EGP suppression by hyperinsulinemia in fcHF-fed and fcHFHS-fed rats was significantly decreased compared with chow-fed rats. One week fcHFHS diet also significantly decreased Rd. Neither EGP suppression nor Rd was affected in fcHS-fed rats. Our results imply that, short-term fat feeding impaired hepatic insulin sensitivity, whereas short-term consumption of both saturated fat and sugar water impaired hepatic and peripheral insulin sensitivity. The latter likely contributed to glucose intolerance observed previously. In contrast, overconsumption of only sugar water affected insulin sensitivity slightly, but not significantly, in spite of similar adiposity as fcHF-fed rats and higher sugar intake compared with fcHFHS-fed rats. These data imply that the palatable component consumed plays a role in the development of site-specific insulin sensitivity.
Search for other papers by François van Herp in
Google Scholar
PubMed
Search for other papers by Nick H M van Bakel in
Google Scholar
PubMed
Search for other papers by Anton J M Coenen in
Google Scholar
PubMed
Search for other papers by Kjell Sergeant in
Google Scholar
PubMed
Search for other papers by Bart Devreese in
Google Scholar
PubMed
Search for other papers by Gerard J M Martens in
Google Scholar
PubMed
To study in vivo the dynamics of the biosynthetic and secretory processes in a neuroendocrine cell, we use the proopiomelanocortin-producing intermediate pituitary melanotrope cells of Xenopus laevis. The activity of these cells can be simply manipulated by adapting the animal to a white or a black background, resulting in inactive and hyperactive cells respectively. Here, we applied differential display proteomics and field emission scanning electron microscopy (FESEM) to examine the changes in architecture accompanying the gradual transition of the inactive to the hyperactive melanotrope cells. The proteomic analysis showed differential expression of neuroendocrine secretory proteins, endoplasmic reticulum (ER)-resident chaperones, and housekeeping and metabolic proteins. The FESEM study revealed changes in the ultrastructure of the ER and Golgi and the number of secretory granules. We conclude that activation of neuroendocrine cells tunes their molecular machineries and organelles to become professional secretors.
Search for other papers by Emma Castrique in
Google Scholar
PubMed
Search for other papers by Marta Fernandez-Fuente in
Google Scholar
PubMed
Search for other papers by Paul Le Tissier in
Google Scholar
PubMed
Search for other papers by Andy Herman in
Google Scholar
PubMed
Search for other papers by Andy Levy in
Google Scholar
PubMed
In rats, a shift from somatotroph dominance to lactotroph dominance during pregnancy and lactation is well reported. Somatotroph to lactotroph transdifferentiation and increased lactotroph mitotic activity are believed to account for this and associated pituitary hypertrophy. A combination of cell death and transdifferentiation away from the lactotroph phenotype has been reported to restore non-pregnant pituitary proportions after weaning. To attempt to confirm that a similar process occurs in mice, we generated and used a transgenic reporter mouse model (prolactin (PRL)-Cre/ROSA26-expression of yellow fluorescent protein (EYFP)) in which PRL promoter activity at any time resulted in permanent, stable, and highly specific EYFP. Triple immunochemistry for GH, PRL, and EYFP was used to quantify EYFP+ve, PRL−ve, and GH+ve cell populations during pregnancy and lactation, and for up to 3 weeks after weaning, and concurrent changes in cell size were estimated. At all stages, the EYFP reporter was expressed in 80% of the lactotrophs, but in fewer than 1% of other pituitary cell types, indicating that transdifferentiation from those lactotrophs where reporter expression was activated is extremely rare. Contrary to expectations, no increase in the lactotroph/somatotroph ratio was seen during pregnancy and lactation, whether assessed by immunochemistry for the reporter or PRL: findings confirmed by PRL immunochemistry in non-transgenic mice. Mammosomatotrophs were rarely encountered at the age group studied. Individual EYFP+ve cell volumes increased significantly by mid-lactation compared with virgin animals. This, in combination with a modest and non-cell type-specific estrogen-induced increase in mitotic activity, could account for pregnancy-induced changes in overall pituitary size.
Departments of Physiology and Pharmacology and
Cell and Developmental Biology, Oregon Health and Science University, 505 NW 185th Ave., Beaverton, OR 97006, USA
Search for other papers by P Michael Conn in
Google Scholar
PubMed
Departments of Physiology and Pharmacology and
Cell and Developmental Biology, Oregon Health and Science University, 505 NW 185th Ave., Beaverton, OR 97006, USA
Search for other papers by Jo Ann Janovick in
Google Scholar
PubMed
Departments of Physiology and Pharmacology and
Cell and Developmental Biology, Oregon Health and Science University, 505 NW 185th Ave., Beaverton, OR 97006, USA
Search for other papers by Shaun P Brothers in
Google Scholar
PubMed
Departments of Physiology and Pharmacology and
Cell and Developmental Biology, Oregon Health and Science University, 505 NW 185th Ave., Beaverton, OR 97006, USA
Search for other papers by Paul E Knollman in
Google Scholar
PubMed
The great writer and polyglot, W Somerset Maugham said, ‘I’ll give you my opinion of the human race in a nutshell...their heart’s in the right place, but their head is a thoroughly inefficient organ.’ If his words are applied to trafficking of the human pituitary gonadotropin-releasing hormone receptor, it turns out that he was more right than he knew. Paradoxically, the inefficiency of receptor trafficking to the plasma membrane can bring regulatory advantages to cells. Understanding the mechanism by which cells recognize correctly folded proteins in health and disease opens doors to new therapeutic approaches and provides a more accurate view of mechanisms of normal cell function than is presently available.
Center for Neuropharmacology and Neurosciences, Albany Medical College, Albany, New York 12208, USA
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
Search for other papers by Eric D Bruder in
Google Scholar
PubMed
Center for Neuropharmacology and Neurosciences, Albany Medical College, Albany, New York 12208, USA
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
Search for other papers by Lauren Jacobson in
Google Scholar
PubMed
Center for Neuropharmacology and Neurosciences, Albany Medical College, Albany, New York 12208, USA
Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
Search for other papers by Hershel Raff in
Google Scholar
PubMed
Ghrelin, leptin, and endogenous glucocorticoids play a role in appetite regulation, energy balance, and growth. The present study assessed the effects of dexamethasone (DEX) on these hormones, and on ACTH and pituitary proopiomelanocortin (POMC) and corticotropin-releasing hormone receptor-1 (CRHR1) mRNA expression, during a common metabolic stress – neonatal hypoxia. Newborn rats were raised in room air (21% O2) or under normobaric hypoxia (12% O2) from birth to postnatal day (PD) 7. DEX was administered on PD3 (0.5 mg/kg), PD4 (0.25 mg/kg), PD5 (0.125 mg/kg), and PD6 (0.05 mg/kg). Pups were studied on PD7 (24 h after the last dose of DEX). DEX significantly increased plasma leptin and ghrelin in normoxic pups, but only increased ghrelin in hypoxic pups. Hypoxia alone resulted in a small increase in plasma leptin. Plasma corticosterone and pituitary POMC mRNA expression were decreased 24 h following the last dose of DEX, whereas plasma ACTH and pituitary CRHR1 mRNA expression had already increased (normoxia and hypoxia). Hypoxia alone increased corticosterone, but had no effect on ACTH or pituitary POMC and CRHR1 mRNA expression. Neonatal DEX treatment, hypoxia, and the combination of both affect hormones involved in energy homeostasis. Pituitary function in the neonate was quickly restored following DEX-induced suppression of the hypothalamic–pituitary–adrenal axis. The changes in ghrelin, leptin, and corticosterone may be beneficial to the hypoxic neonate through the maintenance of appetite and shifts in intermediary metabolism.
Search for other papers by Ángela Sánchez in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
Search for other papers by Constanza Contreras-Jurado in
Google Scholar
PubMed
Search for other papers by Diego Rodríguez in
Google Scholar
PubMed
Search for other papers by Javier Regadera in
Google Scholar
PubMed
Search for other papers by Susana Alemany in
Google Scholar
PubMed
Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain
Search for other papers by Ana Aranda in
Google Scholar
PubMed
Hypothyroidism is often associated with anemia and immunological disorders. Similar defects are found in patients and in mice with a mutated dominant-negative thyroid hormone receptor α (TRα) and in knockout mice devoid of this receptor, suggesting that this isoform is responsible for the effects of the thyroid hormones in hematopoiesis. However, the hematological phenotype of mice lacking also TRβ has not yet been examined. We show here that TRα1/TRβ-knockout female mice, lacking all known thyroid hormone receptors with capacity to bind thyroid hormones, do not have overt anemia and in contrast with hypothyroid mice do not present reduced Gata1 or Hif1 gene expression. Similar to that found in hypothyroidism or TRα deficiency during the juvenile period, the B-cell population is reduced in the spleen and bone marrow of ageing TRα1/TRβ-knockout mice, suggesting that TRβ does not play a major role in B-cell development. However, splenic hypotrophy is more marked in hypothyroid mice than in TRα1/TRβ-knockout mice and the splenic population of T-lymphocytes is not significantly impaired in these mice in contrast with the reduction found in hypothyroidism. Our results show that the overall hematopoietic phenotype of the TRα1/TRβ-knockout mice is milder than that found in the absence of hormone. Although other mechanism/s cannot be ruled out, our results suggest that the unoccupied TRs could have a negative effect on hematopoiesis, likely secondary to repression of hematopoietic gene expression.
Search for other papers by Cecilia Brännmark in
Google Scholar
PubMed
Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
Search for other papers by Emma I Kay in
Google Scholar
PubMed
Search for other papers by Unn Örtegren Kugelberg in
Google Scholar
PubMed
Search for other papers by Belén Chanclón in
Google Scholar
PubMed
Search for other papers by Man Mohan Shrestha in
Google Scholar
PubMed
Search for other papers by Ingrid Wernstedt Asterholm in
Google Scholar
PubMed
Search for other papers by Peter Strålfors in
Google Scholar
PubMed
Search for other papers by Charlotta S Olofsson in
Google Scholar
PubMed
Here we have investigated the role of the protein caveolin 1 (Cav1) and caveolae in the secretion of the white adipocyte hormone adiponectin. Using mouse primary subcutaneous adipocytes genetically depleted of Cav1, we show that the adiponectin secretion, stimulated either adrenergically or by insulin, is abrogated while basal (unstimulated) release of adiponectin is elevated. Adiponectin secretion is similarly affected in wildtype mouse and human adipocytes where the caveolae structure was chemically disrupted. The altered ex vivo secretion in adipocytes isolated from Cav1 null mice is accompanied by lowered serum levels of the high-molecular weight (HMW) form of adiponectin, whereas the total concentration of adiponectin is unaltered. Interestingly, levels of HMW adiponectin are maintained in adipose tissue from Cav1-depleted mice, signifying that a secretory defect is present. The gene expression of key regulatory proteins known to be involved in cAMP/adrenergically triggered adiponectin exocytosis (the beta-3-adrenergic receptor and exchange protein directly activated by cAMP) remains intact in Cav1 null adipocytes. Microscopy and fractionation studies indicate that adiponectin vesicles do not co-localise with Cav1 but that some vesicles are associated with a specific fraction of caveolae. Our studies propose that Cav1 has an important role in secretion of HMW adiponectin, even though adiponectin-containing vesicles are not obviously associated with this protein. We suggest that Cav1, and/or the caveolae domain, is essential for the organisation of signalling pathways involved in the regulation of HMW adiponectin exocytosis, a function that is disrupted in Cav1/caveolae-depleted adipocytes.
Search for other papers by Esther Nuñez-Durán in
Google Scholar
PubMed
Department of Metabolic Physiology, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Belén Chanclón in
Google Scholar
PubMed
Search for other papers by Silva Sütt in
Google Scholar
PubMed
Search for other papers by Joana Real in
Google Scholar
PubMed
Search for other papers by Hanns-Ulrich Marschall in
Google Scholar
PubMed
Search for other papers by Ingrid Wernstedt Asterholm in
Google Scholar
PubMed
Search for other papers by Emmelie Cansby in
Google Scholar
PubMed
Search for other papers by Margit Mahlapuu in
Google Scholar
PubMed
Characterising the molecular networks that negatively regulate pancreatic β-cell function is essential for understanding the underlying pathogenesis and developing new treatment strategies for type 2 diabetes. We recently identified serine/threonine protein kinase 25 (STK25) as a critical regulator of ectopic fat storage, meta-inflammation, and fibrosis in liver and skeletal muscle. Here, we assessed the role of STK25 in control of progression of non-alcoholic fatty pancreas disease in the context of chronic exposure to dietary lipids in mice. We found that overexpression of STK25 in high-fat-fed transgenic mice aggravated diet-induced lipid storage in the pancreas compared with that of wild-type controls, which was accompanied by exacerbated pancreatic inflammatory cell infiltration, stellate cell activation, fibrosis and apoptosis. Pancreas of Stk25 transgenic mice also displayed a marked decrease in islet β/α-cell ratio and alteration in the islet architecture with an increased presence of α-cells within the islet core, whereas islet size remained similar between genotypes. After a continued challenge with a high-fat diet, lower levels of fasting plasma insulin and C-peptide, and higher levels of plasma leptin, were detected in Stk25 transgenic vs wild-type mice. Furthermore, the glucose-stimulated insulin secretion was impaired in high-fat-fed Stk25 transgenic mice during glucose tolerance test, in spite of higher net change in blood glucose concentrations compared with wild-type controls, suggesting islet β-cell dysfunction. In summary, this study unravels a role for STK25 in determining the susceptibility to diet-induced non-alcoholic fatty pancreas disease in mice in connection to obesity. Our findings highlight STK25 as a potential drug target for metabolic disease.
Search for other papers by Corinne Caillaud in
Google Scholar
PubMed
Search for other papers by Mie Mechta in
Google Scholar
PubMed
Search for other papers by Heidi Ainge in
Google Scholar
PubMed
Exercise Health and Performance, Faculty of Health and Medical Sciences, Department of Neuroscience and Pharmacology, School of Medicine and Pharmacology, UMR CNRS 9214, Physiology Department, Department of Endocrinology, Inflammation and Infection Research, Faculty of Health Sciences, and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Andreas N Madsen in
Google Scholar
PubMed
Search for other papers by Patricia Ruell in
Google Scholar
PubMed
Search for other papers by Emilie Mas in
Google Scholar
PubMed
Search for other papers by Catherine Bisbal in
Google Scholar
PubMed
Exercise Health and Performance, Faculty of Health and Medical Sciences, Department of Neuroscience and Pharmacology, School of Medicine and Pharmacology, UMR CNRS 9214, Physiology Department, Department of Endocrinology, Inflammation and Infection Research, Faculty of Health Sciences, and Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
Search for other papers by Jacques Mercier in
Google Scholar
PubMed
Search for other papers by Stephen Twigg in
Google Scholar
PubMed
Search for other papers by Trevor A Mori in
Google Scholar
PubMed
Search for other papers by David Simar in
Google Scholar
PubMed
Search for other papers by Romain Barrès in
Google Scholar
PubMed
Erythropoietin (EPO) ameliorates glucose metabolism through mechanisms not fully understood. In this study, we investigated the effect of EPO on glucose metabolism and insulin signaling in skeletal muscle. A 2-week EPO treatment of rats fed with a high-fat diet (HFD) improved fasting glucose levels and glucose tolerance, without altering total body weight or retroperitoneal fat mass. Concomitantly, EPO partially rescued insulin-stimulated AKT activation, reduced markers of oxidative stress, and restored heat-shock protein 72 expression in soleus muscles from HFD-fed rats. Incubation of skeletal muscle cell cultures with EPO failed to induce AKT phosphorylation and had no effect on glucose uptake or glycogen synthesis. We found that the EPO receptor gene was expressed in myotubes, but was undetectable in soleus. Together, our results indicate that EPO treatment improves glucose tolerance but does not directly activate the phosphorylation of AKT in muscle cells. We propose that the reduced systemic inflammation or oxidative stress that we observed after treatment with EPO could contribute to the improvement of whole-body glucose metabolism.
Search for other papers by Stuart A Lanham in
Google Scholar
PubMed
Search for other papers by Dominique Blache in
Google Scholar
PubMed
Search for other papers by Richard O C Oreffo in
Google Scholar
PubMed
Search for other papers by Abigail L Fowden in
Google Scholar
PubMed
Department of Biological and Medical Sciences, Oxford Brookes University, Oxford, UK
Search for other papers by Alison J Forhead in
Google Scholar
PubMed
Hormones have an important role in the regulation of fetal growth and development, especially in response to nutrient availability in utero. Using micro-CT and an electromagnetic three-point bend test, this study examined the effect of pancreas removal at 0.8 fraction of gestation on the developing bone structure and mechanical strength in fetal sheep. When fetuses were studied at 10 and 25 days after surgery, pancreatectomy caused hypoinsulinaemia, hyperglycaemia and growth retardation which was associated with low plasma concentrations of leptin and a marker of osteoclast activity and collagen degradation. In pancreatectomized fetuses compared to control fetuses, limb lengths were shorter, and trabecular (Tb) bone in the metatarsi showed greater bone volume fraction, Tb thickness, degree of anisotropy and porosity, and lower fractional bone surface area and Tb spacing. Mechanical strength testing showed that pancreas deficiency was associated with increased stiffness and a greater maximal weight load at fracture in a subset of fetuses studied near term. Overall, pancreas deficiency in utero slowed the growth of the fetal skeleton and adapted the developing bone to generate a more compact and connected structure. Maintenance of bone strength in growth-retarded limbs is especially important in a precocial species in preparation for skeletal loading and locomotion at birth.
